FDA asks for more studies on Bayer's Essure birth control device 29.02.2016 21:56 Reuters (Reuters) - The U.S. Food and Drug Administration has asked German drugmaker Bayer AG to conduct further studies on its controversial birth control device, Essure, and recommended that the product label contains the most restrictive type of warning.
